FDA Warning Letter — Stirling Exxon

Case 505955 — FEI 3012625216

The FDA took a Warning Letter action against Stirling Exxon on Aug 4, 2016 (Stirling, NJ). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Stirling Exxon
Date
Aug 4, 2016
Fiscal Year
2016
Product Type
Tobacco
Center
CTP
Location
Stirling, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.